DSN
BIIB icon

D. Scott Neal’s Biogen BIIB Stock Holding History

D. Scott Neal’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$27K – 79
2018
Q1 		$27K Hold
100
– – 0.02% 103
2017
Q4 		$32K Hold
100
– – 0.02% 93
2017
Q3 		$31K Hold
100
– – 0.02% 95
2017
Q2 		$27K Hold
100
– – 0.02% 116
2017
Q1 		$27K Hold
100
– – 0.02% 99
2016
Q4 		$28K Hold
100
– – 0.02% 91
2016
Q3 		$31K Hold
100
– – 0.02% 82
2016
Q2 		$24K Hold
100
– – 0.02% 86
2016
Q1 		$26K Sell
100
-100
-50% -$26.4K 0.02% 70
2015
Q4 		$61K Buy
+200
New +$57.5K 0.05% 58

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D. Scott Neal's BIIB Position: Q2 2018 in Review

D. Scott Neal sold out of Biogen (BIIB) in Q2 2018, closing a stake of 100 shares — an estimated $27K sold.

D. Scott Neal first reported a position in BIIB in Q4 2015 and held it in 10 quarters. The position peaked at $61K in Q4 2015. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • D. Scott Neal reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • D. Scott Neal sold 100 Biogen shares in Q2 2018, an estimated $27K.
  • D. Scott Neal first reported a position in Biogen in Q4 2015 and held it in 10 quarters.
  • D. Scott Neal's Biogen position peaked at $61K in Q4 2015.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on D. Scott Neal's 13F filing for Q2 2018, filed 15 Aug 2018.